Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Beyond the Abstract. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Beyond the Abstract or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Plaque Hacks: When it Comes to Statins, Consistency is Key

16:29
 
Share
 

Manage episode 463394565 series 3236172
Content provided by Beyond the Abstract. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Beyond the Abstract or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Cardiovascular disease is the leading cause of global mortality. Among the many risk factors for cardiovascular disease, it's long been known that high cholesterol increases the risk for heart attacks and stroke. In today's episode of Beyond the Abstract, Derek and Dan discuss two new papers that challenge commonly held beliefs about the way in which cholesterol increases the risk for cardiovascular disease. They finish by talking about a new type of genetic medicine to lower cholesterol and reduce the risk for cardiovascular disease.

Papers discussed

Alternating high-fat diet enhances atherosclerosis by neutrophil reprogramming, Lavillegrand et al 2024 Nature

https://www.nature.com/articles/s41586-024-07693-6

Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis, Takaoka et al 2024 Nature

https://www.nature.com/articles/s41586-024-07993-x

Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia, Rosenson et al 2024 NEJM

http://nejm.org/doi/full/10.1056/NEJMoa2404147

Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia, Ballantyne et al 2024 NEJM

https://www.nejm.org/doi/full/10.1056/NEJMoa2404143

  continue reading

43 episodes

Artwork
iconShare
 
Manage episode 463394565 series 3236172
Content provided by Beyond the Abstract. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Beyond the Abstract or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Cardiovascular disease is the leading cause of global mortality. Among the many risk factors for cardiovascular disease, it's long been known that high cholesterol increases the risk for heart attacks and stroke. In today's episode of Beyond the Abstract, Derek and Dan discuss two new papers that challenge commonly held beliefs about the way in which cholesterol increases the risk for cardiovascular disease. They finish by talking about a new type of genetic medicine to lower cholesterol and reduce the risk for cardiovascular disease.

Papers discussed

Alternating high-fat diet enhances atherosclerosis by neutrophil reprogramming, Lavillegrand et al 2024 Nature

https://www.nature.com/articles/s41586-024-07693-6

Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis, Takaoka et al 2024 Nature

https://www.nature.com/articles/s41586-024-07993-x

Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia, Rosenson et al 2024 NEJM

http://nejm.org/doi/full/10.1056/NEJMoa2404147

Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia, Ballantyne et al 2024 NEJM

https://www.nejm.org/doi/full/10.1056/NEJMoa2404143

  continue reading

43 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play